Literature DB >> 2736210

Production of transforming growth factor-alpha in human tumour cell lines.

K Imanishi1, K Yamaguchi, M Suzuki, S Honda, N Yanaihara, K Abe.   

Abstract

Forty-one human tumour cell lines were examined for the production of epidermal growth factor (EGF)/transforming growth factor (TGF)-alpha-like activity (EGF/TGF-alpha-LA), immunoreactive (IR-) EGF and IR-TGF-alpha. EGF/TGF-alpha-LA was determined by radioreceptor assay, in which the factors with capacity to bind to EGF receptor could be detected. IR-EGF and IR-TGF-alpha were determined by the respective radioimmunoassays. Both EGF/TGF-alpha-LA and IR-TGF-alpha were detected in 11 tumour cell lines. The levels of EGF/TGF-alpha-LA correlated well with those of IR-TGF-alpha. A small amount of IR-TGF-alpha was detected in five other lines. In contrast, IR-EGF was not detectable in any of the 41. Consequently, it can be concluded that EGF/TGF-alpha-LA produced by human tumour cells is mainly TGF-alpha rather than EGF. It was also revealed that melanoma cell lines produce a large amount of TGF-alpha frequently. Gel filtration studies revealed that TGF-alpha produced by melanoma cell lines was identical to human (h) TGF-alpha(1-50), except for one line, in which IR-TGF-alpha with a different molecular size was detected. Northern blot analysis revealed that bands corresponding to hTGF-alpha mRNA were present in melanoma cell lines producing a large amount of IR-TGF-alpha, indicating that the TGF-alpha produced is the product of hTGF-alpha gene. Further studies are required to discover the actual biological roles of TGF-alpha produced by melanoma cells as well as other types of cancer cells.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2736210      PMCID: PMC2247206          DOI: 10.1038/bjc.1989.159

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  23 in total

1.  Production of transforming growth factor alpha in human pancreatic cancer cells: evidence for a superagonist autocrine cycle.

Authors:  J J Smith; R Derynck; M Korc
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

2.  Age-related decrease of urinary excretion of human epidermal growth factor (hEGF).

Authors:  M Uchihashi; Y Hirata; T Fujita; S Matsukura
Journal:  Life Sci       Date:  1982-08-16       Impact factor: 5.037

3.  Inability of anti-epidermal growth factor receptor monoclonal antibody to block "autocrine" growth stimulation in transforming growth factor-secreting melanoma cells.

Authors:  J E Kudlow; M J Khosravi; M S Kobrin; W W Mak
Journal:  J Biol Chem       Date:  1984-10-10       Impact factor: 5.157

4.  UVR induction of TGF alpha: a possible autocrine mechanism for the epidermal melanocytic response and for promotion of epidermal carcinogenesis.

Authors:  K A Ellem; M Cullinan; K C Baumann; A Dunstan
Journal:  Carcinogenesis       Date:  1988-05       Impact factor: 4.944

5.  Immunological detection and quantitation of alpha transforming growth factors in human breast carcinoma cells.

Authors:  I Perroteau; D Salomon; M DeBortoli; W Kidwell; P Hazarika; R Pardue; J Dedman; J Tam
Journal:  Breast Cancer Res Treat       Date:  1986       Impact factor: 4.872

6.  Different transforming growth factor-alpha species are derived from a glycosylated and palmitoylated transmembrane precursor.

Authors:  T S Bringman; P B Lindquist; R Derynck
Journal:  Cell       Date:  1987-02-13       Impact factor: 41.582

7.  Synthesis of messenger RNAs for transforming growth factors alpha and beta and the epidermal growth factor receptor by human tumors.

Authors:  R Derynck; D V Goeddel; A Ullrich; J U Gutterman; R D Williams; T S Bringman; W H Berger
Journal:  Cancer Res       Date:  1987-02-01       Impact factor: 12.701

8.  Biological effect of epidermal growth factor on the in vitro growth of human tumors.

Authors:  S E Singletary; F L Baker; G Spitzer; S L Tucker; B Tomasovic; W A Brock; J A Ajani; A M Kelly
Journal:  Cancer Res       Date:  1987-01-15       Impact factor: 12.701

9.  Integral membrane glycoprotein properties of the prohormone pro-transforming growth factor-alpha.

Authors:  J Teixidó; R Gilmore; D C Lee; J Massagué
Journal:  Nature       Date:  1987 Apr 30-May 6       Impact factor: 49.962

10.  Comparison of seven cell lines derived from human gastric carcinomas.

Authors:  T Motoyama; H Hojo; H Watanabe
Journal:  Acta Pathol Jpn       Date:  1986-01
View more
  18 in total

1.  The application of a novel biotinylated affinity label for the detection of a cathepsin B-like precursor produced by breast-tumour cells in culture.

Authors:  B M Cullen; I M Halliday; G Kay; J Nelson; B Walker
Journal:  Biochem J       Date:  1992-04-15       Impact factor: 3.857

2.  Cell-to-cell contact as an efficient mode of Epstein-Barr virus infection of diverse human epithelial cells.

Authors:  S Imai; J Nishikawa; K Takada
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

3.  Enhanced gene expression of transforming growth factor-alpha and c-met in rat urinary bladder cancer.

Authors:  M Inui; N Nishi; A Yasumoto; I Takenaka; H Miyanaka; K Matsumoto; T Nakamura; F Wada
Journal:  Urol Res       Date:  1996

4.  Serum response heterogeneity among nonsmall cell lung cancer cell lines.

Authors:  K T Goldsmith; C M Listinsky; R I Garver
Journal:  Am J Pathol       Date:  1991-10       Impact factor: 4.307

5.  Bacterial toxins induce sustained mRNA expression of the silencing transcription factor klf2 via inactivation of RhoA and Rhophilin 1.

Authors:  Kristina Dach; Josip Zovko; Michael Hogardt; Isabel Koch; Katrin van Erp; Jürgen Heesemann; Reinhard Hoffmann
Journal:  Infect Immun       Date:  2009-09-28       Impact factor: 3.441

6.  Immunoreactive transforming growth factor alpha is commonly present in colorectal neoplasia.

Authors:  S Tanaka; K Imanishi; M Yoshihara; K Haruma; K Sumii; G Kajiyama; S Akamatsu
Journal:  Am J Pathol       Date:  1991-07       Impact factor: 4.307

Review 7.  Growth factors in melanoma.

Authors:  U Rodeck; M Herlyn
Journal:  Cancer Metastasis Rev       Date:  1991-06       Impact factor: 9.264

8.  Epidermal growth factor and transforming growth factor alpha characteristics of human oral carcinoma cell lines.

Authors:  S S Prime; S M Game; J B Matthews; A Stone; M J Donnelly; W A Yeudall; V Patel; R Sposto; A Silverthorne; C Scully
Journal:  Br J Cancer       Date:  1994-01       Impact factor: 7.640

9.  Production of endothelin-1 and thrombomodulin by human pancreatic cancer cells.

Authors:  T Oikawa; M Kushuhara; S Ishikawa; J Hitomi; A Kono; T Iwanaga; K Yamaguchi
Journal:  Br J Cancer       Date:  1994-06       Impact factor: 7.640

10.  Production of parathyroid hormone-related protein in tumour xenografts in nude mice presenting with hypercalcaemia.

Authors:  Y Miyake; K Yamaguchi; S Honda; K Nagasaki; T Tsuchihashi; M Mori; S Kimura; K Abe
Journal:  Br J Cancer       Date:  1991-02       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.